APA (7th ed.) Citation

CK, F., MCS, C., JM, M., ST, A., AD, C., DQB, M., . . . MG, T. (2019). Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma. The Journal of clinical endocrinology and metabolism, 104(8), 3245. https://doi.org/10.1210/jc.2018-02221

Chicago Style (17th ed.) Citation

CK, Falcao, et al. "Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma." The Journal of Clinical Endocrinology and Metabolism 104, no. 8 (2019): 3245. https://doi.org/10.1210/jc.2018-02221.

MLA (9th ed.) Citation

CK, Falcao, et al. "Acquired Lipodystrophy Associated With Nivolumab in a Patient With Advanced Renal Cell Carcinoma." The Journal of Clinical Endocrinology and Metabolism, vol. 104, no. 8, 2019, p. 3245, https://doi.org/10.1210/jc.2018-02221.